GLP-3 RT 60mg Peptides
Built for precision-driven studies, this research peptide is formulated to meet exacting expectations without compromise.
Primavora GLP-3 RT is supplied as a lyophilized peptide vial designed for controlled laboratory work. This unadulterated, non-flavored format features GLP-3 RT as the active ingredient with a total content of 60mg per vial, supporting methodical handling, careful aliquoting, and consistent outcomes across qualified research settings.
- Each vial contains 60mg of GLP-3 RT, provided as a lyophilized research peptide to support stability, reliable reconstitution, and reproducible protocol development.
Developed for non-ingestible, laboratory use, this format prioritizes clarity and control from bench to record. The lyophilized matrix is designed for predictable handling in compliant environments, enabling accurate measurements, standardized procedures, and dependable batch-to-batch consistency. With a straightforward presentation and no distracting flavors or additives, researchers can focus on the compound itself and the integrity of each step within their workflow.
Every vial reflects Primavoras disciplined approach to quality. As a USA-based research brand, we emphasize sourcing, handling, and documentation standards that align with rigorous laboratory expectations. Each lot is produced and filled under controlled conditions and is lot-tested for identity and purity, with a certificate of analysis available to support verification and internal QC review. Transparent labeling, tamper-evident packaging, and careful lot control help safeguard traceability and confidence from arrival through final data capture.
Primavora is built around precision and reliability: clear specifications, professional presentation, and a consistent experience that respects your methods and data. For institutions, labs, and qualified professionals, GLP-3 RT 60mg offers a dependable option when protocol consistency and compound integrity come first. Store and handle according to standard laboratory practices and your internal SOPs.
For laboratory research only. Not for human or animal consumption, clinical use, or household use. Sale is intended exclusively for qualified professionals and controlled research environments.
Trust Primavora a modern, research-first peptide source committed to purity, consistency, and transparent documentation on every lot.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Prima Vora are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
